TY - JOUR
T1 - Does prior microsurgery improve or worsen the outcomes of stereotactic radiosurgery for cavernous sinus meningiomas?
AU - Kano, Hideyuki
AU - Park, Kyun Jae
AU - Kondziolka, Douglas
AU - Iyer, Aditya
AU - Liu, Xiaomin
AU - Tonetti, Daniel
AU - Flickinger, John C.
AU - Lunsford, L. Dade
PY - 2013/9
Y1 - 2013/9
N2 - Background: Stereotactic radiosurgery (SRS) is an important option for patients with cavernous sinus meningiomas. Objective: To evaluate cranial nerve outcomes in patients who underwent SRS for cavernous sinus meningiomas with or without prior microsurgery. Methods: During a 23-year interval, 272 patients underwent Gamma Knife SRS for cavernous sinus meningiomas (70 men, 202 women; median age, 54 years). In this series, 99 patients underwent prior microsurgical resection. The median tumor volume was 7.9 cm and median marginal dose was 13 Gy. The median follow-up period was 62 months (range, 6-209 months). Results: The progression-free survival after SRS was 96% at 3 years, 94% at 5 years, and 86% at 10 years. After SRS, 13 of 91 patients (14%) who underwent prior microsurgery had improvement of preexisting cranial nerve symptoms or signs. In comparison, 54 of 145 patients (37%) without prior microsurgery had improvement of preexisting cranial nerve symptoms or signs. The improvement rate of cranial nerve deficits after SRS in patients without prior microsurgery was 20% at 1 year, 34% at 2 years, 36% at 3 years, and 39% at 5 years. Patients who had not undergone prior microsurgery had significantly higher improvement rates of preexisting cranial nerve symptoms and signs (P = .001). After SRS, 29 patients (11%) developed new or worsened cranial nerve function. Conclusion: SRS provided long-term effective tumor control and a low risk of new cranial nerve deficits. Improvement in preexisting cranial neuropathies was detected in significantly more patients who had not undergone prior microsurgical procedures.
AB - Background: Stereotactic radiosurgery (SRS) is an important option for patients with cavernous sinus meningiomas. Objective: To evaluate cranial nerve outcomes in patients who underwent SRS for cavernous sinus meningiomas with or without prior microsurgery. Methods: During a 23-year interval, 272 patients underwent Gamma Knife SRS for cavernous sinus meningiomas (70 men, 202 women; median age, 54 years). In this series, 99 patients underwent prior microsurgical resection. The median tumor volume was 7.9 cm and median marginal dose was 13 Gy. The median follow-up period was 62 months (range, 6-209 months). Results: The progression-free survival after SRS was 96% at 3 years, 94% at 5 years, and 86% at 10 years. After SRS, 13 of 91 patients (14%) who underwent prior microsurgery had improvement of preexisting cranial nerve symptoms or signs. In comparison, 54 of 145 patients (37%) without prior microsurgery had improvement of preexisting cranial nerve symptoms or signs. The improvement rate of cranial nerve deficits after SRS in patients without prior microsurgery was 20% at 1 year, 34% at 2 years, 36% at 3 years, and 39% at 5 years. Patients who had not undergone prior microsurgery had significantly higher improvement rates of preexisting cranial nerve symptoms and signs (P = .001). After SRS, 29 patients (11%) developed new or worsened cranial nerve function. Conclusion: SRS provided long-term effective tumor control and a low risk of new cranial nerve deficits. Improvement in preexisting cranial neuropathies was detected in significantly more patients who had not undergone prior microsurgical procedures.
KW - Cavernous sinus
KW - Cranial nerve deficits
KW - Gamma Knife
KW - Meningioma
KW - Stereotactic radiosurgery
UR - http://www.scopus.com/inward/record.url?scp=84883263184&partnerID=8YFLogxK
U2 - 10.1227/01.neu.0000431471.64289.3d
DO - 10.1227/01.neu.0000431471.64289.3d
M3 - Article
C2 - 23719052
AN - SCOPUS:84883263184
SN - 0148-396X
VL - 73
SP - 401
EP - 410
JO - Neurosurgery
JF - Neurosurgery
IS - 3
ER -